[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global RNA Drugs Market Professional Survey Report 2017

August 2017 | 110 pages | ID: GBDE7168629EN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies RNA Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • Pfizer
  • Roche
  • Sanofi-Aventis
  • Abbott Laboratories
  • Arrowhead Pharmaceuticals
  • Benitec Biopharma
  • Calimmune Inc
  • Dicerna
  • Gradalis
  • Quark
  • RXi
  • Senesco
  • Silence Therapeutics
  • Silenseed
  • Tekmira
  • Alnylam Pharmaceuticals
By types, the market can be split into
  • siRNA
  • ASO
  • miRNA
  • Nucleic Acid Aptamers
By Application, the market can be split into
  • Cancer
  • Diabetes
  • Tuberculosis
  • Cardiovascular Diseases
  • Others
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global RNA Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF RNA DRUGS

1.1 Definition and Specifications of RNA Drugs
  1.1.1 Definition of RNA Drugs
  1.1.2 Specifications of RNA Drugs
1.2 Classification of RNA Drugs
  1.2.1 siRNA
  1.2.2 ASO
  1.2.3 miRNA
  1.2.4 Nucleic Acid Aptamers
1.3 Applications of RNA Drugs
  1.3.1 Cancer
  1.3.2 Diabetes
  1.3.3 Tuberculosis
  1.3.4 Cardiovascular Diseases
  1.3.5 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF RNA DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of RNA Drugs
2.3 Manufacturing Process Analysis of RNA Drugs
2.4 Industry Chain Structure of RNA Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF RNA DRUGS

3.1 Capacity and Commercial Production Date of Global RNA Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global RNA Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global RNA Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global RNA Drugs Major Manufacturers in 2016

4 GLOBAL RNA DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global RNA Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 RNA Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global RNA Drugs Sales and Growth Rate Analysis
  4.3.2 2016 RNA Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global RNA Drugs Sales Price
  4.4.2 2016 RNA Drugs Sales Price Analysis (Company Segment)

5 RNA DRUGS REGIONAL MARKET ANALYSIS

5.1 North America RNA Drugs Market Analysis
  5.1.1 North America RNA Drugs Market Overview
  5.1.2 North America 2012-2017E RNA Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E RNA Drugs Sales Price Analysis
  5.1.4 North America 2016 RNA Drugs Market Share Analysis
5.2 China RNA Drugs Market Analysis
  5.2.1 China RNA Drugs Market Overview
  5.2.2 China 2012-2017E RNA Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E RNA Drugs Sales Price Analysis
  5.2.4 China 2016 RNA Drugs Market Share Analysis
5.3 Europe RNA Drugs Market Analysis
  5.3.1 Europe RNA Drugs Market Overview
  5.3.2 Europe 2012-2017E RNA Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E RNA Drugs Sales Price Analysis
  5.3.4 Europe 2016 RNA Drugs Market Share Analysis
5.4 Southeast Asia RNA Drugs Market Analysis
  5.4.1 Southeast Asia RNA Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E RNA Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E RNA Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 RNA Drugs Market Share Analysis
5.5 Japan RNA Drugs Market Analysis
  5.5.1 Japan RNA Drugs Market Overview
  5.5.2 Japan 2012-2017E RNA Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E RNA Drugs Sales Price Analysis
  5.5.4 Japan 2016 RNA Drugs Market Share Analysis
5.6 India RNA Drugs Market Analysis
  5.6.1 India RNA Drugs Market Overview
  5.6.2 India 2012-2017E RNA Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E RNA Drugs Sales Price Analysis
  5.6.4 India 2016 RNA Drugs Market Share Analysis

6 GLOBAL 2012-2017E RNA DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E RNA Drugs Sales by Type
6.2 Different Types of RNA Drugs Product Interview Price Analysis
6.3 Different Types of RNA Drugs Product Driving Factors Analysis
  6.3.1 siRNA of RNA Drugs Growth Driving Factor Analysis
  6.3.2 ASO of RNA Drugs Growth Driving Factor Analysis
  6.3.3 miRNA of RNA Drugs Growth Driving Factor Analysis
  6.3.4 Nucleic Acid Aptamers of RNA Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E RNA DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E RNA Drugs Consumption by Application
7.2 Different Application of RNA Drugs Product Interview Price Analysis
7.3 Different Application of RNA Drugs Product Driving Factors Analysis
  7.3.1 Cancer of RNA Drugs Growth Driving Factor Analysis
  7.3.2 Diabetes of RNA Drugs Growth Driving Factor Analysis
  7.3.3 Tuberculosis of RNA Drugs Growth Driving Factor Analysis
  7.3.4 Cardiovascular Diseases of RNA Drugs Growth Driving Factor Analysis
  7.3.5 Others of RNA Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF RNA DRUGS

8.1 Pfizer
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Pfizer 2016 RNA Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Pfizer 2016 RNA Drugs Business Region Distribution Analysis
8.2 Roche
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Roche 2016 RNA Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Roche 2016 RNA Drugs Business Region Distribution Analysis
8.3 Sanofi-Aventis
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Sanofi-Aventis 2016 RNA Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Sanofi-Aventis 2016 RNA Drugs Business Region Distribution Analysis
8.4 Abbott Laboratories
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Abbott Laboratories 2016 RNA Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Abbott Laboratories 2016 RNA Drugs Business Region Distribution Analysis
8.5 Arrowhead Pharmaceuticals
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Arrowhead Pharmaceuticals 2016 RNA Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Arrowhead Pharmaceuticals 2016 RNA Drugs Business Region Distribution Analysis
8.6 Benitec Biopharma
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Benitec Biopharma 2016 RNA Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Benitec Biopharma 2016 RNA Drugs Business Region Distribution Analysis
8.7 Calimmune Inc
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Calimmune Inc 2016 RNA Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Calimmune Inc 2016 RNA Drugs Business Region Distribution Analysis
8.8 Dicerna
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Dicerna 2016 RNA Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Dicerna 2016 RNA Drugs Business Region Distribution Analysis
8.9 Gradalis
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Gradalis 2016 RNA Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Gradalis 2016 RNA Drugs Business Region Distribution Analysis
8.10 Quark
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Quark 2016 RNA Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Quark 2016 RNA Drugs Business Region Distribution Analysis
8.11 RXi
8.12 Senesco
8.13 Silence Therapeutics
8.14 Silenseed
8.15 Tekmira
8.16 Alnylam Pharmaceuticals

9 DEVELOPMENT TREND OF ANALYSIS OF RNA DRUGS MARKET

9.1 Global RNA Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 RNA Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 RNA Drugs Sales Price Forecast
9.2 RNA Drugs Regional Market Trend
  9.2.1 North America 2017-2022 RNA Drugs Consumption Forecast
  9.2.2 China 2017-2022 RNA Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 RNA Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 RNA Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 RNA Drugs Consumption Forecast
  9.2.6 India 2017-2022 RNA Drugs Consumption Forecast
9.3 RNA Drugs Market Trend (Product Type)
9.4 RNA Drugs Market Trend (Application)

10 RNA DRUGS MARKETING TYPE ANALYSIS

10.1 RNA Drugs Regional Marketing Type Analysis
10.2 RNA Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of RNA Drugs by Region
10.4 RNA Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF RNA DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL RNA DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of RNA Drugs
Table Product Specifications of RNA Drugs
Table Classification of RNA Drugs
Figure Global Production Market Share of RNA Drugs by Type in 2016
Figure siRNA Picture
Table Major Manufacturers of siRNA
Figure ASO Picture
Table Major Manufacturers of ASO
Figure miRNA Picture
Table Major Manufacturers of miRNA
Figure Nucleic Acid Aptamers Picture
Table Major Manufacturers of Nucleic Acid Aptamers
Table Applications of RNA Drugs
Figure Global Consumption Volume Market Share of RNA Drugs by Application in 2016
Figure Cancer Examples
Table Major Consumers in Cancer
Figure Diabetes Examples
Table Major Consumers in Diabetes
Figure Tuberculosis Examples
Table Major Consumers in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Major Consumers in Cardiovascular Diseases
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of RNA Drugs by Regions
Figure North America RNA Drugs Market Size (Million USD) (2012-2022)
Figure China RNA Drugs Market Size (Million USD) (2012-2022)
Figure Europe RNA Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia RNA Drugs Market Size (Million USD) (2012-2022)
Figure Japan RNA Drugs Market Size (Million USD) (2012-2022)
Figure India RNA Drugs Market Size (Million USD) (2012-2022)
Table RNA Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of RNA Drugs in 2016
Figure Manufacturing Process Analysis of RNA Drugs
Figure Industry Chain Structure of RNA Drugs
Table Capacity and Commercial Production Date of Global RNA Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global RNA Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global RNA Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global RNA Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of RNA Drugs 2012-2017
Figure Global 2012-2017E RNA Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E RNA Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global RNA Drugs Capacity and Growth Rate
Table 2016 Global RNA Drugs Capacity (K Units) List (Company Segment)
Table 2012-2017E Global RNA Drugs Sales (K Units) and Growth Rate
Table 2016 Global RNA Drugs Sales (K Units) List (Company Segment)
Table 2012-2017E Global RNA Drugs Sales Price (USD/Unit)
Table 2016 Global RNA Drugs Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of RNA Drugs 2012-2017E
Figure North America 2012-2017E RNA Drugs Sales Price (USD/Unit)
Figure North America 2016 RNA Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of RNA Drugs 2012-2017E
Figure China 2012-2017E RNA Drugs Sales Price (USD/Unit)
Figure China 2016 RNA Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of RNA Drugs 2012-2017E
Figure Europe 2012-2017E RNA Drugs Sales Price (USD/Unit)
Figure Europe 2016 RNA Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of RNA Drugs 2012-2017E
Figure Southeast Asia 2012-2017E RNA Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2016 RNA Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of RNA Drugs 2012-2017E
Figure Japan 2012-2017E RNA Drugs Sales Price (USD/Unit)
Figure Japan 2016 RNA Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of RNA Drugs 2012-2017E
Figure India 2012-2017E RNA Drugs Sales Price (USD/Unit)
Figure India 2016 RNA Drugs Sales Market Share
Table Global 2012-2017E RNA Drugs Sales (K Units) by Type
Table Different Types RNA Drugs Product Interview Price
Table Global 2012-2017E RNA Drugs Sales (K Units) by Application
Table Different Application RNA Drugs Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer RNA Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer RNA Drugs Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche RNA Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche RNA Drugs Business Region Distribution
Table Sanofi-Aventis Information List
Table Product A Overview
Table Product B Overview
Table 2015 Sanofi-Aventis RNA Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi-Aventis RNA Drugs Business Region Distribution
Table Abbott Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Laboratories RNA Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Abbott Laboratories RNA Drugs Business Region Distribution
Table Arrowhead Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Arrowhead Pharmaceuticals RNA Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Arrowhead Pharmaceuticals RNA Drugs Business Region Distribution
Table Benitec Biopharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Benitec Biopharma RNA Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Benitec Biopharma RNA Drugs Business Region Distribution
Table Calimmune Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Calimmune Inc RNA Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Calimmune Inc RNA Drugs Business Region Distribution
Table Dicerna Information List
Table Product A Overview
Table Product B Overview
Table 2016 Dicerna RNA Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Dicerna RNA Drugs Business Region Distribution
Table Gradalis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Gradalis RNA Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Gradalis RNA Drugs Business Region Distribution
Table Quark Information List
Table Product A Overview
Table Product B Overview
Table 2016 Quark RNA Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Quark RNA Drugs Business Region Distribution
Table RXi Information List
Table Senesco Information List
Table Silence Therapeutics Information List
Table Silenseed Information List
Table Tekmira Information List
Table Alnylam Pharmaceuticals Information List
Figure Global 2017-2022 RNA Drugs Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 RNA Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 RNA Drugs Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 RNA Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 RNA Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 RNA Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 RNA Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 RNA Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 RNA Drugs Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of RNA Drugs by Type 2017-2022
Table Global Consumption Volume (K Units) of RNA Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of RNA Drugs by Region


More Publications